Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines

Corporate Breaking News

Home : Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines

Jun 27 2022	Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines
TAIZHOU, China, June 27, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. is pleased to announce that, the Group has recently received the clinical trial approval (the"Clinical Trial Approval") for its R520A, a mRNA COVID-19 vaccine ("R520A"), from the Food and Drug Administration...


Source:https://www.prnewswire.com:443/news-releases/clinical-trial-approval-for-mrna-covid-19-vaccine-for-omicron-variant-in-the-philippines-301575485.html

Related News
» ProtOnART - a new consortium for proton online adaptive radiation therapy » Elbit Systems Awarded $70 Million Contract to Provide EW Solution to an International Customer